USPTO Examiner NGUYEN TRAN N - Art Unit 3685

Recent Applications

Detailed information about the 100 most recent patent applications.

Application NumberTitleFiling DateDisposal DateDispositionTime (months)Office ActionsRestrictionsInterviewAppeal
19189025System and Method for Emotionally Intelligent, Personalized AI Avatar-Based Health Coaching Using Multi-Domain Data and Adaptive Behavioral IntelligenceApril 2025January 2026Allow910YesNo
18607945COMPUTER-IMPLEMENTED SYSTEMS AND METHODS FOR MULTI-LEVEL DATA GROUPING AND GENERATION OF A HIERARCHICAL DATA DISPLAY FROM UNIFORM CLAIMS DATAMarch 2024March 2025Allow1200NoNo
18598265Multi-Factor Authentication and Post-Authentication Processing SystemMarch 2024March 2025Allow1200NoNo
18397494CLOUD BASED VIEWING, TRANSFER AND STORAGE OF MEDICAL DATADecember 2023June 2025Abandon1810NoNo
18538387MANAGING HEALTHCARE SERVICESDecember 2023December 2024Allow1300NoNo
18514845METHOD AND USES OF DIAGNOSING AND RECOMMENDING TREATMENT FOR A PSYCHOTIC DISORDERNovember 2023March 2025Allow1600NoNo
18228272DISEASE MONITORING FROM INSURANCE CLAIMS DATAJuly 2023March 2025Abandon2020NoNo
18274271METHOD FOR ANALYSIS OF OMICS DATAJuly 2023January 2026Allow3010NoNo
18348540DISTRIBUTED RULES BASED HIERARCHICAL AUDITING SYSTEM FOR MANAGEMENT OF HEALTH CARE SERVICESJuly 2023June 2025Abandon2320YesNo
18134124Self-learning Method of Hydrating a HumanApril 2023November 2025Abandon3110NoNo
18177221SURGERY SYSTEM, CONTROL METHOD, SURGICAL APPARATUS, AND PROGRAMMarch 2023July 2025Abandon2840YesNo
17975095METHOD AND APPARATUS FOR PLANNING PLACEMENT OF AN IMPLANTOctober 2022January 2026Allow3830YesNo
17913252RADIOLOGY QUALITY DASHBOARD DATA ANALYSIS AND INSIGHT ENGINESeptember 2022October 2025Abandon3720YesNo
17939629SPINAL STENOSIS DETECTION AND GENERATION OF SPINAL DECOMPRESSION PLANSeptember 2022October 2025Allow3750YesNo
17907775INTELLIGENT TRIAGE METHOD AND DEVICE, STORAGE MEDIUM AND ELECTRONIC DEVICEAugust 2022December 2025Allow4020YesNo
17795353A Portable Memory Device For Use With An Infusion DeviceJuly 2022October 2025Allow3830YesNo
17794904METHODS, SYSTEMS, AND DEVICES FOR PROCESSING HEALTH-RELATED INFORMATIONJuly 2022September 2025Abandon3801NoNo
17794900AUTOMATED CONVERSION OF DRUG LIBRARIESJuly 2022October 2025Allow3920NoNo
17859530INVENTORY SYSTEMS AND METHODS FOR DETECTING AND COUNTING POTENTIALLY RETAINED SURGICAL ITEMSJuly 2022January 2026Allow4220YesNo
17806846CONNECTED BODY SURFACE CARE MODULEJune 2022June 2025Abandon3610NoNo
17735750Clinical Pathway Integration and Clinical Decision SupportMay 2022June 2025Abandon3710NoNo
17706073ELECTRONIC DEVICE AND METHOD OF PROVIDING HEALTH GUIDELINE USING THE SAMEMarch 2022June 2025Allow3830YesNo
17683229WORKSTATION INTEGRATING MULTIPLE DISTINCT COMPUTING SYSTEMSFebruary 2022March 2025Allow3720YesNo
17590461REMOTE VIRTUAL AND AUGMENTED REALITY MONITORING AND CONTROL SYSTEMSFebruary 2022May 2025Abandon3920NoNo
17626480METHODS AND SYSTEMS FOR OPTIMIZING DRUG MANAGEMENTJanuary 2022January 2026Allow4830YesNo
17453273MANAGING CAREGIVER MESSAGESNovember 2021June 2025Allow4330YesNo
17453246ACCESS TO MULTIPLE CAREGIVER INFORMATION SYSTEMSNovember 2021January 2025Allow3930YesNo
17499963Systems and Methods for On-Device Real-Time Access and Review of Events during a Patient Treatment EpisodeOctober 2021October 2025Abandon4840YesNo
17499449SYSTEM AND METHOD FOR REMOTE AUTHENTICATED TESTING APPLICATIONSOctober 2021January 2025Abandon3920NoNo
17483319MACHINE LEARNING TECHNIQUES FOR GENERATING HISTORICALLY DYNAMIC EXPLANATION DATA OBJECTSSeptember 2021July 2025Allow4620YesNo
17459542METHODS AND SYSTEMS FOR IMPLEMENTING AND USING DIGITAL IMAGING AND COMMUNICATIONS IN MEDICINE (DICOM) STRUCTURED REPORTING (SR) OBJECT CONSOLIDATIONAugust 2021December 2024Abandon3920YesNo
17459006MULTI-STAGE WORKFLOW PROCESSING AND ANALYSIS PLATFORMAugust 2021December 2025Allow5240YesNo
17432044SYSTEMS AND METHODS FOR SYNCHRONIZING A DEVICE CLOCK IN WOUND MONITORING AND/OR TREATMENT SYSTEMSAugust 2021November 2025Allow5131YesNo
17402746SYSTEM AND METHOD FOR MONITORING COMPLIANCE AND PARTICIPANT SAFETY FOR CLINICAL TRIALSAugust 2021November 2024Abandon3920NoNo
17388128CLINICAL DECISION SUPPORTJuly 2021February 2026Allow5450YesNo
17361103METHOD OR APPARATUS FOR PROVIDING DIAGNOSTIC RESULTSJune 2021October 2025Abandon5140YesNo
17325653RISK ASSESSMENT AND RISK REDUCTION IN TISSUE COLLECTION AND PROCESSINGMay 2021February 2025Abandon4510NoNo
17163614OPTIMIZED CLIENT-STAFF COMMUNICATION SYSTEMS DEVICES AND METHODS FORDIGITAL HEALTH FACILITYFebruary 2021May 2025Abandon5230YesNo
17123679THERAPEUTIC ZONE ASSESSORDecember 2020January 2026Allow6060YesNo
17096785JOINT STATE ESTIMATION PREDICTION THAT EVALUATES DIFFERENCES IN PREDICTED VS. CORRESPONDING RECEIVED DATANovember 2020November 2025Abandon6060YesNo
17086147MEDICAL DEVICE SITE MONITORING METHODS AND RELATED DEVICES AND SYSTEMSOctober 2020January 2025Allow5130YesNo
17085554Eating Disorder DiagnosisOctober 2020March 2025Abandon5330YesNo
17075202DATA-DRIVEN DESCRIPTIVE AND PRESCRIPTIVE ANALYTICS FOR MEDICAL DEVICESOctober 2020September 2025Allow5950YesNo
16944736SYSTEMS, DEVICES, AND METHODS RELATING TO MEDICATION DOSE GUIDANCEJuly 2020October 2025Allow6070YesNo
16926913CLOUD-BASED METHOD AND SYSTEM FOR EXTRACTION AND DISPLAY OF CLINICALLY-RELEVANT ACTIONABLE PATIENT DATA FROM MULTIPLE ELECTRONIC MEDICAL RECORDSJuly 2020September 2025Abandon6060NoNo
16704550Blood Purification SystemDecember 2019August 2025Allow6080YesNo
16417231SYSTEMS AND METHODS FOR PROVIDNG AN INDUCEMENT FOR A PURCHASE IN CONJUNCTION WITH A PRESCRIPTIONMay 2019June 2025Abandon6040NoYes
16387401METHOD AND SYSTEM FOR PROVIDING PATIENT DATA TO A PATIENT DATA SERVER FOLLOWING AN OFFLINE NETWORK CONDITIONApril 2019October 2024Allow6060YesNo
16220072Artificial Intelligence Quality Measures Data ExtractorDecember 2018December 2022Abandon4850NoNo
13866615APPARATUS AND METHOD FOR MANAGING INTERACTION-BASED SERVICESApril 2013June 2014Allow1410NoNo
13674656SYSTEM AND METHOD FOR STANDARDIZED AND AUTOMATED APPEALS PROCESSNovember 2012October 2013Allow1110NoNo
13473498SYSTEM AND METHOD FOR STANDARDIZED AND AUTOMATED APPEALS PROCESSMay 2012November 2012Allow610NoNo
13289872COMPUTER-BASED SYSTEM FOR AUTOMATING ADMINISTRATIVE PROCEDURES IN AN OFFICENovember 2011January 2014Allow2720NoNo
13199064INSURANCE ON DEMAND TRANSACTION MANAGEMENT SYSTEMAugust 2011June 2013Allow2220YesNo
13061172METHOD AND DEVICE FOR PROVIDING COMPENSATED STAFF DATAJune 2011September 2013Allow3110NoNo
13113845SYSTEMS, METHODS, AND APPARATUS FOR USE IN GATHERING AND PROVIDING HEALTHCARE INFORMATIONMay 2011December 2013Allow3120YesNo
12931892Method for linking insurance policiesFebruary 2011May 2013Allow2730NoNo
12858069APPARATUS AND METHOD FOR CONSTRUCTING FORMULARIESAugust 2010July 2011Allow1110NoNo
12773334METHOD OF OPTIMIZING HEALTHCARE SERVICES CONSUMPTIONMay 2010April 2011Allow1110NoNo
12767752USE OF INTERNET SITE AS A REGISTRY FOR RESULTS OF MEDICAL TESTSApril 2010June 2013Allow3830NoNo
12679680IMAGE RECONSTRUCTING METHOD USING X-RAY VOLUME PHOTOGRAPHYMarch 2010December 2013Allow4430NoNo
12661680METHOD FOR LINKING INSURANCE POLICIESMarch 2010October 2010Allow610NoNo
12661669METHOD FOR LINKING INSURANCE POLICIESMarch 2010February 2012Allow2330NoNo
12728850SYSTEM AND METHOD FOR AUTOMATICALLY AND ITERATIVELY PRODUCING AND UPDATING PATIENT SUMMARY ENCOUNTER REPORTS BASED ON RECOGNIZED PATTERNS OF OCCURRENCESMarch 2010March 2011Allow1220YesNo
12711912PATIENT ROOM AND BED MANAGEMENT APPARATUS AND SYSTEMFebruary 2010March 2014Allow4941NoNo
12589591SYSTEMS AND METHODS FOR PROVIDING SUPPLEMENTAL INSURANCE FOR LEASED VEHICLESOctober 2009April 2011Allow1810NoNo
12575653METHODS AND APPARATUS FOR ANALYZING MEDICAL IMAGING DATAOctober 2009November 2013Allow4920NoNo
12561139POINT SPREAD FUNCTION RADIAL COMPONENT IMPLEMENTATION IN JOSEPH'S FORWARD PROJECTORSeptember 2009June 2013Allow4540YesNo
12368519APPARATUS AND METHOD FOR CONSTRUCTING FORMULARIESFebruary 2009April 2010Allow1410NoNo
12158052ELECTRONIC AGENDA WITH WEIGHT MANAGEMENT FUNCTIONJune 2008February 2013Allow5650NoNo
11969221INTEGRATED SYSTEM FOR GENERATION AND RETENTION OF MEDICAL RECORDSJanuary 2008January 2011Allow3720YesNo
11874258BIOMEDICAL FEEDBACK METHOD AND SYSTEMOctober 2007January 2014Allow6030NoNo
11973754HEALTHCARE PROVIDER PERFORMANCE AND UTILIZATION ANALYTICSOctober 2007March 2011Allow4110NoNo
11838055METHOD FOR RENEWING MEDICAL PRESCRIPTIONSAugust 2007June 2009Allow2220NoNo
11776499SYSTEM AND METHOD FOR PROVIDING OPTIMIZED MEDICAL ORDER SETSJuly 2007May 2011Allow4620NoNo
11695357SYSTEM AND METHOD FOR HEALTHCARE ADVISORY SYSTEMApril 2007April 2011Allow4980NoNo
11562953SYSTEM & METHOD FOR THE DESIGN, CREATION AND INSTALLATION OF IMPLANT-SUPPORTED DENTAL PROSTHESESNovember 2006August 2012Abandon6050YesNo
11510864STRUCTURED DATA AUTHORING AND EDITING SYSTEMAugust 2006August 2010Allow4840YesNo
11275403FACILITATING PAYMENTS TO HEALTH CARE PROVIDERSDecember 2005March 2011Allow6071NoNo
10813421METHOD FOR IDENTIFYING ALLERGENS AND OTHER INFLUENCING AGENTS THAT MAY CAUSE A REACTIONMarch 2004August 2009Allow6020YesYes
10751820SYSTEM AND METHOD FOR RISK-ADJUSTING INDICATORS OF ACCESS AND UTILIZATION BASED ON METRICS OF DISTANCE AND TIMEJanuary 2004September 2009Allow6040YesNo
10729444UNEMPLOYMENT RISK SCORE AND PRIVATE INSURANCE FOR EMPLOYEESDecember 2003September 2013Allow6040NoNo
10686705MEDICAL EQUIPMENT MANAGEMENT APPARATUS WHICH PREDICTS FUTURE STATUS OF MEDICAL EQUIPMENTOctober 2003March 2013Allow6091YesYes
10655804SYSTEM FOR THE ACQUISITION OF TECHNOLOGY RISK MITIGATION INFORMATION ASSOCIATED WITH INSURANCESeptember 2003August 2009Allow6030YesNo
10384114METHOD AND SYSTEM FOR IMPLEMENTING AND TRACKING COST-SAVING MEASURES IN HOSPITALS AND COMPENSATING PHYSICIANSMarch 2003August 2008Allow6060YesNo
10316024SYSTEM AND METHOD FOR DETERMINING THE COST OF A PHARMACEUTICALDecember 2002May 2013Allow6080YesNo
10315959INSURANCE ON DEMAND TRANSACTION MANAGEMENT SYSTEMDecember 2002December 2007Allow6010NoNo
10065159METHODS AND SYSTEMS FOR MANAGING CLINICAL RESEARCH INFORMATIONSeptember 2002September 2010Allow6020NoYes
10229620INSURANCE METHOD, INSURANCE SYSTEM, TRANSACTION MONITORING METHOD, TRANSACTION MONITORING SYSTEM, AND PROGRAMAugust 2002September 2007Allow6020NoNo
09853703METHOD, APPARATUS, AND MEDIUM USING A MASTER CONTROL FILE FOR COMPUTER SOFTWARE INTEROPERABILITY BETWEEN DISPARATE OPERATING SYSTEMSMay 2001April 2007Abandon60100NoYes

Appeals Overview

This analysis examines appeal outcomes and the strategic value of filing appeals for examiner NGUYEN, TRAN N.

Patent Trial and Appeal Board (PTAB) Decisions

Total PTAB Decisions
3
Examiner Affirmed
1
(33.3%)
Examiner Reversed
2
(66.7%)
Reversal Percentile
87.6%
Higher than average

What This Means

With a 66.7% reversal rate, the PTAB has reversed the examiner's rejections more often than affirming them. This reversal rate is in the top 25% across the USPTO, indicating that appeals are more successful here than in most other areas.

Strategic Value of Filing an Appeal

Total Appeal Filings
5
Allowed After Appeal Filing
2
(40.0%)
Not Allowed After Appeal Filing
3
(60.0%)
Filing Benefit Percentile
67.1%
Higher than average

Understanding Appeal Filing Strategy

Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.

In this dataset, 40.0% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is above the USPTO average, suggesting that filing an appeal can be an effective strategy for prompting reconsideration.

Strategic Recommendations

Appeals to PTAB show good success rates. If you have a strong case on the merits, consider fully prosecuting the appeal to a Board decision.

Filing a Notice of Appeal is strategically valuable. The act of filing often prompts favorable reconsideration during the mandatory appeal conference.

Examiner NGUYEN, TRAN N - Prosecution Strategy Guide

Executive Summary

Examiner NGUYEN, TRAN N works in Art Unit 3685 and has examined 65 patent applications in our dataset. With an allowance rate of 78.5%, this examiner has a below-average tendency to allow applications. Applications typically reach final disposition in approximately 49 months.

Allowance Patterns

Examiner NGUYEN, TRAN N's allowance rate of 78.5% places them in the 46% percentile among all USPTO examiners. This examiner has a below-average tendency to allow applications.

Office Action Patterns

On average, applications examined by NGUYEN, TRAN N receive 3.48 office actions before reaching final disposition. This places the examiner in the 94% percentile for office actions issued. This examiner issues more office actions than most examiners, which may indicate thorough examination or difficulty in reaching agreement with applicants.

Prosecution Timeline

The median time to disposition (half-life) for applications examined by NGUYEN, TRAN N is 49 months. This places the examiner in the 7% percentile for prosecution speed. Applications take longer to reach final disposition with this examiner compared to most others.

Interview Effectiveness

Conducting an examiner interview provides a -2.0% benefit to allowance rate for applications examined by NGUYEN, TRAN N. This interview benefit is in the 9% percentile among all examiners. Note: Interviews show limited statistical benefit with this examiner compared to others, though they may still be valuable for clarifying issues.

Request for Continued Examination (RCE) Effectiveness

When applicants file an RCE with this examiner, 19.4% of applications are subsequently allowed. This success rate is in the 20% percentile among all examiners. Strategic Insight: RCEs show lower effectiveness with this examiner compared to others. Consider whether a continuation application might be more strategic, especially if you need to add new matter or significantly broaden claims.

After-Final Amendment Practice

This examiner enters after-final amendments leading to allowance in 24.1% of cases where such amendments are filed. This entry rate is in the 32% percentile among all examiners. Strategic Recommendation: This examiner shows below-average receptiveness to after-final amendments. You may need to file an RCE or appeal rather than relying on after-final amendment entry.

Pre-Appeal Conference Effectiveness

When applicants request a pre-appeal conference (PAC) with this examiner, 0.0% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 20% percentile among all examiners. Note: Pre-appeal conferences show limited success with this examiner compared to others. While still worth considering, be prepared to proceed with a full appeal brief if the PAC does not result in favorable action.

Appeal Withdrawal and Reconsideration

This examiner withdraws rejections or reopens prosecution in 57.1% of appeals filed. This is in the 31% percentile among all examiners. Of these withdrawals, 50.0% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner shows below-average willingness to reconsider rejections during appeals. Be prepared to fully prosecute appeals if filed.

Petition Practice

When applicants file petitions regarding this examiner's actions, 69.2% are granted (fully or in part). This grant rate is in the 76% percentile among all examiners. Strategic Note: Petitions are frequently granted regarding this examiner's actions compared to other examiners. Per MPEP § 1002.02(c), various examiner actions are petitionable to the Technology Center Director, including prematureness of final rejection, refusal to enter amendments, and requirement for information. If you believe an examiner action is improper, consider filing a petition.

Examiner Cooperation and Flexibility

Examiner's Amendments: This examiner makes examiner's amendments in 13.8% of allowed cases (in the 96% percentile). Per MPEP § 1302.04, examiner's amendments are used to place applications in condition for allowance when only minor changes are needed. This examiner frequently uses this tool compared to other examiners, indicating a cooperative approach to getting applications allowed. Strategic Insight: If you are close to allowance but minor claim amendments are needed, this examiner may be willing to make an examiner's amendment rather than requiring another round of prosecution.

Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.0% of allowed cases (in the 43% percentile). This examiner issues Quayle actions less often than average. Allowances may come directly without a separate action for formal matters.

Prosecution Strategy Recommendations

Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:

  • Expect multiple rounds of prosecution: This examiner issues more office actions than average. Address potential issues proactively in your initial response and consider requesting an interview early in prosecution.
  • Plan for extended prosecution: Applications take longer than average with this examiner. Factor this into your continuation strategy and client communications.
  • Examiner cooperation: This examiner frequently makes examiner's amendments to place applications in condition for allowance. If you are close to allowance, the examiner may help finalize the claims.

Relevant MPEP Sections for Prosecution Strategy

  • MPEP § 713.10: Examiner interviews - available before Notice of Allowance or transfer to PTAB
  • MPEP § 714.12: After-final amendments - may be entered "under justifiable circumstances"
  • MPEP § 1002.02(c): Petitionable matters to Technology Center Director
  • MPEP § 1004: Actions requiring primary examiner signature (allowances, final rejections, examiner's answers)
  • MPEP § 1207.01: Appeal conferences - mandatory for all appeals
  • MPEP § 1214.07: Reopening prosecution after appeal

Important Disclaimer

Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.

No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.

Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.

Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.